19.45
+0.30
+(1.57%)
At close: 7:31:05 PM GMT+1
Breakdown
TTM
9/30/2024
9/30/2023
9/30/2022
9/30/2021
Operating Cash Flow
-462,851.00
-462,851.00
-153,890.00
-136,131.00
171,312.00
Investing Cash Flow
-420,072.00
-420,072.00
-96,155.00
-5,417.00
-141,678.00
Financing Cash Flow
870,520.00
870,520.00
253,053.00
65,186.00
11,305.00
End Cash Position
102,685.00
102,685.00
110,891.00
108,005.00
184,434.00
Income Tax Paid Supplemental Data
3,744.00
3,744.00
--
2.00
2.00
Capital Expenditure
-141,469.00
-141,469.00
-176,737.00
-52,777.00
-23,567.00
Issuance of Capital Stock
429,265.00
429,265.00
--
--
--
Issuance of Debt
392,000.00
392,000.00
--
--
--
Repayment of Debt
-0.00
--
--
--
--
Free Cash Flow
-604,320.00
-604,320.00
-330,627.00
-188,908.00
147,745.00
9/30/2021 - 4/30/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MDG1.HM Medigene AG
1.7400
-7.45%
NVV1.BE Novavax Inc
8.41
-7.24%
NVAX.MX Novavax, Inc.
185.00
+0.54%
NVV1.F Novavax, Inc.
8.51
+0.05%
MDG1.DE Medigene AG
1.7500
-2.78%
CAMP CAMP4 THERAPEUTICS CORPORATION
5.90
+18.71%
BOLT Bolt Biotherapeutics, Inc.
0.5029
+0.90%
IFRX InflaRx N.V.
2.3700
+5.80%
KRRO Korro Bio, Inc.
34.18
+3.29%
VERA Vera Therapeutics, Inc.
37.48
-1.19%